BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 1396560)

  • 1. A novel antifolate resistance gene on the amplified H circle of Leishmania.
    Papadopoulou B; Roy G; Ouellette M
    EMBO J; 1992 Oct; 11(10):3601-8. PubMed ID: 1396560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A member of the aldoketo reductase family confers methotrexate resistance in Leishmania.
    Callahan HL; Beverley SM
    J Biol Chem; 1992 Dec; 267(34):24165-8. PubMed ID: 1339441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the locus and of the resistance gene on gene amplification frequency in methotrexate resistant Leishmania tarentolae.
    Kündig C; Leblanc E; Papadopoulou B; Ouellette M
    Nucleic Acids Res; 1999 Sep; 27(18):3653-9. PubMed ID: 10471733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent amplification of a short chain dehydrogenase gene as part of circular and linear amplicons in methotrexate resistant Leishmania.
    Papadopoulou B; Roy G; Ouellette M
    Nucleic Acids Res; 1993 Sep; 21(18):4305-12. PubMed ID: 8414986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The amplified H circle of methotrexate-resistant leishmania tarentolae contains a novel P-glycoprotein gene.
    Ouellette M; Fase-Fowler F; Borst P
    EMBO J; 1990 Apr; 9(4):1027-33. PubMed ID: 1969794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pteridine reductase gene ptr1 contiguous to a P-glycoprotein confers resistance to antifolates in Trypanosoma cruzi.
    Robello C; Navarro P; Castanys S; Gamarro F
    Mol Biochem Parasitol; 1997 Dec; 90(2):525-35. PubMed ID: 9476799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of extrachromosomal circular amplicons with direct or inverted duplications in drug-resistant Leishmania tarentolae.
    Grondin K; Roy G; Ouellette M
    Mol Cell Biol; 1996 Jul; 16(7):3587-95. PubMed ID: 8668175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct and inverted DNA repeats associated with P-glycoprotein gene amplification in drug resistant Leishmania.
    Ouellette M; Hettema E; Wüst D; Fase-Fowler F; Borst P
    EMBO J; 1991 Apr; 10(4):1009-16. PubMed ID: 1672636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance and P-glycoprotein gene amplification in the protozoan parasite Leishmania.
    Ouellette M; Borst P
    Res Microbiol; 1991; 142(6):737-46. PubMed ID: 1961984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplified DNAs in laboratory stocks of Leishmania tarentolae: extrachromosomal circles structurally and functionally similar to the inverted-H-region amplification of methotrexate-resistant Leishmania major.
    Petrillo-Peixoto ML; Beverley SM
    Mol Cell Biol; 1988 Dec; 8(12):5188-99. PubMed ID: 3244352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in folate and pterin metabolism after disruption of the Leishmania H locus short chain dehydrogenase gene.
    Papadopoulou B; Roy G; Mourad W; Leblanc E; Ouellette M
    J Biol Chem; 1994 Mar; 269(10):7310-5. PubMed ID: 8125946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification of the H locus in Leishmania infantum.
    Chiquero MJ; Olmo A; Navarro P; Ruiz-Perez LM; Castanys S; Gonzalez-Pacanowska D; Gamarro F
    Biochim Biophys Acta; 1994 Nov; 1227(3):188-94. PubMed ID: 7986827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant PTR1 proteins from Leishmania tarentolae: comparative kinetic properties and active-site labeling.
    Chang CF; Bray T; Whiteley JM
    Arch Biochem Biophys; 1999 Aug; 368(1):161-71. PubMed ID: 10415124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New approaches to Leishmania chemotherapy: pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity.
    Nare B; Luba J; Hardy LW; Beverley S
    Parasitology; 1997; 114 Suppl():S101-10. PubMed ID: 9309772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification by extrachromosomal amplification and overexpression of a zeta-crystallin/NADPH-oxidoreductase homologue constitutively expressed in Leishmania spp.
    Liu X; Chang KP
    Mol Biochem Parasitol; 1994 Aug; 66(2):201-10. PubMed ID: 7808470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent amplification of a short chain dehydrogenase gene in methotrexate resistant Leishmania.
    Papadopoulou B; Ouellette M
    Adv Exp Med Biol; 1993; 338():559-62. PubMed ID: 8304180
    [No Abstract]   [Full Text] [Related]  

  • 17. Linear amplicons as precursors of amplified circles in methotrexate-resistant Leishmania tarentolae.
    Grondin K; Kündig C; Roy G; Ouellette M
    Nucleic Acids Res; 1998 Jul; 26(14):3372-8. PubMed ID: 9649621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene amplification in Leishmania tarentolae selected for resistance to sodium stibogluconate.
    Haimeur A; Ouellette M
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1689-94. PubMed ID: 9661005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of the Leishmania tarentolae pterin transporter (BT1) and reductase (PTR1) genes leads to viable parasites with changes in folate metabolism and hypersensitivity to the antifolate methotrexate.
    El Fadili A; Kündig C; Roy G; Ouellette M
    J Biol Chem; 2004 Apr; 279(18):18575-82. PubMed ID: 14981076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and genetic tests for inhibitors of Leishmania pteridine pathways.
    Hardy LW; Matthews W; Nare B; Beverley SM
    Exp Parasitol; 1997 Nov; 87(3):157-69. PubMed ID: 9371081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.